WHC is still in active development. Read this to understand our approach.
depiction of KYYIDSXMWOZKMP-UHFFFAOYSA-N.svg
isomerdesign

Desvenlafaxine

Verificar en isomerdesign

pubchem

Desvenlafaxine

Verificar en pubchem

drugmap

Desvenlafaxine

Verificar en drugmap

wiki

Desvenlafaxine

Verificar en wiki

Data

InChI: InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3

Sinónimos: DESVENLAFAXINE [USP-RS],4-[2-Dimethyamino-1-(1-hydroxycyclohexyl)ethyl]phenol,GTPL7158,AKOS015896311,Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-, Desvenlafaxine (INN),(RS)-1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol,FT-0654519,O-Desmethylvenlafaxine solution, 1.0 mg/mL in methanol, certified reference material,O-desmethyl venlafaxine,EC 700-516-2,EN300-7353726,BCP28517,O-Desmethylvenlafaxine solution,4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)-ethyl)phenol,UNII-NG99554ANW,Venlafaxine O-desmethyl 100 microg/mL in Acetonitrile,AB01563022_01,SW219514-2,1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol,4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol,FT-0666246,DB06700,DESVENLAFAXINE [USP MONOGRAPH],DESVENLAFAXINE [ORANGE BOOK],Newven,DESVENLAFAXINE [MI],HY-B0602,O-Desvenlafaxine, Desvenlafaxine [INN:BAN],Z1741977125,PDSP1_001804,D,L-O-Desmethyl Venlafaxine-[d6],SMR004701214,93413-62-8 (free base),SB17444, O-Desmethylvenlafaxine,NCGC00345883-04,CAS_386750-22-7, O-DESMETHYLVENLAFAXINE (ODV),D07793,HMS3885F05,NG99554ANW,NSC_6918664,BDBM86748,NCGC00345883-07, WY 45,233,Desvenlafaxine,CHEBI:83527,93413-62-8,HSDB 7993,Venlafaxine-M (O-desmethyl),HMS3652K16,4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol #,Mdd-xr,D-veniz,s4113,O-DESMETHYLVENLAFAXINE (ODV),Desvenlafaxine [INN],R-(-)-O-Desmethyl-Venlafaxine,FT-0666245,Q2419445,SCHEMBL34864,DESVENLAFAXINE [WHO-DD],D5598,D,L-O-Desmethyl Venlafaxine,Desvenlafaxine [INN:BAN],DVS 233,DTXSID40869118,4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol,ODV,1-[2-dimethylamino-1-(4-hydroxyphenyl)ethyl]cyclohexanol,Khedezla (TN),A844583,O-Desmethylvenlafaxine,4-[2-(dimethylamino)-1-(1-oxidanylcyclohexyl)ethyl]phenol, WY-45,233,Phenol, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]-,413D628,O-desmethyl-venlafaxine,DESVENLAFAXINE [VANDF],CCG-267081,4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol,(S)-Desmethyl Venlafaxine D6,PDSP2_001787,Khedezla,O-Desmethylvenlafaxine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material,DS-1282,Norvenlafaxine,O-Desmethylvenlafaxine 0.1 mg/ml in Methanol,MFCD00871934,Desvenlafaxine (INN),S-(+)-O-Desmethyl-Venlafaxine,AMY15413,CHEMBL1118,O-Desmethylvenlafaxine, analytical standard,d,l-O-Desmethylvenlafaxine,Venlafaxine O-Desmethyl,MLS006010042

Estimated data

Solubilidad: -1.9 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 48.8% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.